WUSM St. Louis-led Study: Evidence for Polypill Benefits Undeniable, WHO Essential List & Spin-off Pharma to Commercialize

Washington University School of Medicine in St. Louis researcher outcomes recently contributed to mounting evidence that polypills are beneficial in preventing heart attacks and strokes, overall lowering mortality among  people with cardiovascular risk factors, such as high blood pressure and high cholesterol. In fact this study influenced the World Health Organization (WHO) to add polypills to its most recent Model List of Essential Medicines. While the evidence has accumulated for the benefit of polypills for a quarter of a century, the latest study led by the team in St. Louis, plus collaborators in India and Australia lead to commercial spin-off in Australia dedicated to commercializing polypills.

So, what are polypills?